Corona crisis has limited impact on infant participation in National Immunisation Programme Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.
Initial results on how COVID-19 spreads within Dutch families The novel coronavirus is primarily spread amongst adults who are about the same age. Within families, the virus is mainly transmitted from adults to children.
Publication WHO Good Practice Brief RIVM Centre for Healthy Living The Good Practice Brief 'Centre for Healthy Living in the Netherlands: Building sustainable capacity and alliances for effective health promotion' has been published on the World Health Organ
Fewer TB patients in the Netherlands The key figures of the National Institute for Public Health and the Environment (RIVM) show that in 2017, the number of TB patients in the Netherlands fell below 800 TB patients for the first time
Hormone-disrupting effect methyl-, ethyl- and propylparaben still unclear RIVM has conducted literature research into the hormone-disrupting effects of the three most commonly used parabens (methyl-, ethyl- and propylparaben) and the exposure of consumers to these substa
Legislation on maximum permitted amount of synephrine in food supplements is desirable Harmful health effects of dietary supplements with high levels of synephrine, which are used to lose weight or improve sports performance, cannot be excluded.
RIVM develops a framework for a broader view of establishing food safety standards In Europe, strict requirements apply to food safety. Food safety standards are determined at international level.
Less meat and more tap water benefits health and the environment In the Netherlands, diets with a high environmental impact contain more meat and energy.
New standard for exposure assessment of cleaning products RIVM has updated the standard for exposure assessment of cleaning products in the ConsExpo Cleaning Products Fact Sheet.
Off-label use of medicines: Room for improvement Medicinal products may be prescribed for other diseases, or groups of patients, than the ones that they are approved for.